Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 8,112 | 6,463 | 5,242 | 0 |
| Operating Income | -8,112 | -6,463 | -5,242 | N/A |
| Other Income | -4 | -4 | -37 | 0 |
| Pre-tax Income | -8,116 | -6,467 | -5,279 | 0 |
| Net Income Continuous | -8,116 | -6,467 | -5,279 | N/A |
| Net Income | $-8,116 | $-6,467 | $-5,279 | $N/A |
| EPS Basic Total Ops | -11.97 | -9.65 | -7.89 | N/A |
| EPS Basic Continuous Ops | -11.97 | -9.65 | -7.89 | N/A |
| EPS Diluted Total Ops | -11.97 | -9.65 | -7.89 | N/A |
| EPS Diluted Continuous Ops | -11.97 | -9.65 | -7.89 | N/A |
| EBITDA(a) | $-7,938 | $-6,320 | $-5,083 | $N/A |